Drug Abuse Flashcards

1
Q

Which substances are prohibited?

A
  • anabolic agents
  • peptide hormones, growth factors, related substances and mimetics
  • beta-2 agonists
  • hormone and metabolic modulators
  • diuretics and masking agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which methods are prohibited?

A
  • manipulation of blood and blood components
  • chemical and physical
  • gene doping
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which substances and methods are prohibited in-competition?

A
  • stimulants
  • narcotics
  • cannabinoids
  • glucocorticoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which substances are prohibited in particular sports?

A
  • alcohol
  • beta-blockers
  • narcotics
  • cannabinoids
  • glucocorticoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the function of IGF-I?

A
  • stimulates cell proliferation
  • inhibits protein breakdown
  • ability to cause differentiation and proliferation of satellite cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is IGF-I?

A
  • 70 AA polypeptide
  • gene: 6 exons, 2 promoter regions
  • released from liver under control of GH
  • 7 binding proteins regulate its action
  • also produced locally
  • IGF-I receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does direct infusion of IGF-I into muscle of mice cause?

A

Muscle growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is gene doping?

A

Misuse of gene therapy.

“The non-therapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance”

WADA 2001

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the principle of gene therapy?

A
  • delivery to a cell of a therapeutic gene which may correct an abnormal gene
  • directed primarily at single gene disorders (muscular dystrophy, CF, etc)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which genes increase O2 utilisation?

A
  • PGC-1a(lpha)
  • PPARd(elta)
  • PEPCK
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which genes improve O2 delivery?

A
  • EPO

- VEGF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which genes improve muscle mass strength?

A
  • IGF-I

- myostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are TUEs?

A

Therapeutic exemption certificates.

Where med is prescribed + formally declared for bonafide medical reasons (e.g. asthma and beta-2 agonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is L-carnitine?

A

Nutritional supplement.

  • not illegal but q’s over administration e.g. oral vs injection, size of injected
  • inv in mito FA translocation (sub. for carnitine palmitoyl-transferase-1)
  • during high intensity exercise, formation of acetylcarnitine is essential for maintenance of a viable pool of free co-enzyme A, thereby enabling PDC and TCA flux to continue
  • reduces reliance on aerobic metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is melodonium?

A

Metabolic modulator.

Found in Maria Sharapova - tennis player

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Salbutamol?

A

Beta-2 agonist and legal asthma drug.

Going in Chris Froome - top cyclist
Had 2x permitted level in urine sample

17
Q

What happens to protein balance in normal conditions?

A

protein synthesis (MPS) = protein breakdown (MPB)

18
Q

What happens to protein balance in anabolism?

A

Muscle growth.

Increase in MPS, decrease in MPB - or both (net gain)

19
Q

What happens to protein balance in catabolism?

A

Muscle atrophy.

Decrease in MPS, increase in MPB - or both (net loss)

20
Q

What are some dangerous side effects of AAS?

A
  • HA or stroke
  • liver of kidney tumours
  • hypertension
  • blood clots
21
Q

What is EPO?

A
  • glycoprotein produced by kidney in response to low o2
  • stimulates BM to make RBCs
  • synthetic EPO sold as a rescue medicine for treating anemia in end-stage kidney disease, when production of EPO declines
  • increase in RBC number facilitates o2 transport
  • increases vo2 max and endurance performance
  • risk of increased viscosity of blood (increased risk of HA and stroke)
22
Q

What limits vo2 max?

A

O2 carrying capacity

23
Q

What is myostatin gene (GDF-8)?

A

A negative regulator of muscle mass

24
Q

What does lack of myosin result in?

A

Excessive muscle growth but impaired force generation

25
Q

What is VEGF?

A
  • improves micro circulation
  • extensively tested in clinical trials for ischaemic efficacy in cardiac and skeletal muscle diseases
  • limited success - complex regulation of angiogenesis
26
Q

What is the risk of gene doping?

A

Uncontrolled expression:

  • EPO cause increased haematocrit - stroke heart failure
  • GH/IGF - potential risk of oncogenesis
  • insertional mutagenesis
  • myostatin reduces specific force
27
Q

What are some dangerous side effects of AAS?

A
  • HA or stroke
  • liver of kidney tumours
  • hypertension
  • blood clots
28
Q

What is EPO?

A
  • glycoprotein produced by kidney in response to low o2
  • stimulates BM to make RBCs
  • synthetic EPO sold as a rescue medicine for treating anemia in end-stage kidney disease, when production of EPO declines
  • increase in RBC number facilitates o2 transport
  • increases vo2 max and endurance performance
  • risk of increased viscosity of blood (increased risk of HA and stroke)
29
Q

What limits vo2 max?

A

O2 carrying capacity

30
Q

What is myostatin gene (GDF-8)?

A

A negative regulator of muscle mass

31
Q

What does lack of myosin result in?

A

Excessive muscle growth but impaired force generation

32
Q

What is VEGF?

A
  • improves micro circulation
  • extensively tested in clinical trials for ischaemic efficacy in cardiac and skeletal muscle diseases
  • limited success - complex regulation of angiogenesis
33
Q

What is the risk of gene doping?

A

Uncontrolled expression:

  • EPO cause increased haematocrit - stroke heart failure
  • GH/IGF - potential risk of oncogenesis
  • insertional mutagenesis
  • myostatin reduces specific force